Deep expertise. Diverse experience.
Click below to learn more about the strategic guidance and tactical expertise that 3C™ provides:
3C was recognized as a “Top Ancillary Business” by Cannabis Business Executive for the last three years.
3C™ Builds Cannabis Empires.
Leveraging a deep understanding of all areas of cannabis operations, 3C™ helps clients grow in more ways than one.
We are a trusted resource for agricultural, industrial, retail and investment clients looking to achieve superior gains and increased shareholder value. We do this through strategic investment, business guidance and assessment of existing operations.
Our mission is to be the premier advisory firm for cannabis businesses at all stages of development, from basic planning to enterprise-level scaling and international expansion.
The 3C™ approach is completely unique in the commercial marijuana industry; nowhere else is there such vast industry knowledge and proven expertise. Our powerful suite of cannabis business development tools includes:
- Marijuana Business Licensing
- Efficiency and Productivity Audits
- Business Plan Reviews/Writing Services
- Company Structuring
- Investment Management Strategy
- Compliance and Regulatory Evaluations
- Tax and Legal Service Referrals
- Marketing, Advertising, Branding and Distribution Models
- Guidance for Ongoing Growth and Business Scaling
Our approach consistently produces measurably superior cannabis with greater yields at lower costs for our clients. Because 3C™ is aligned with core values related to social, environmental, and economic principles, our clients and their communities prosper in all areas of cannabis operations.
In The Press
Although this is my first Cannabis venture, I don’t anticipate it being my last. I know that I will be teaming with 3C when I go through this process again. I was previously the CEO of a 150 store retail pharmacy chain, so I understand the importance and value in selecting the right consultant. Our group would extend 3C our highest recommendation and our utmost confidence.
Natural State Medicinals
I have worked with many consultants in the past, but I have NEVER seen such a great team working so hard to succeed on an application. I am and will forever be impressed about you, and how fast and professionally you took the approach on this task.
CEO, Cantiva ApS and Relief ApS
I have worked closely with the Team at 3C for more than a year, and they have exceeded my expectations. Whether they are helping cultivators optimize operations, or assisting retailers with sourcing organic products, their working knowledge of the entire value chain is evident in all that they do. They have demonstrated - with ethics and integrity - an ability to understand client needs, develop solutions and mobilize resources efficiently, effectively and in a timely manner. Simply put, the Team at 3C Consulting is world-class.
CEO, New Leaf Data Services, LLC
Commodity Price Reporting Agency
Nic and 3C were a significant help to my indoor cultivation operation. Their unique knowledge allowed me to increase yields and develop processes that saved me time, energy, and money. 3C offered advice on nearly every aspect of my grow from propagation, ventilation and lighting to plant nutrition, pest control, and harvesting. I implemented the suggestions successfully and would recommend 3C’s services without hesitation. I will definitely utilize their services in the future, especially when I am developing my next site.
Colorado Medical Cultivator
Subscribe to our emails for news and updates!
3C Featured Articles
Since the World Health Organization deemed the Coronavirus (i.e., COVID-19) outbreak a global pandemic on March 11, 2020, government bodies on every level—local, statewide, provincial, and national—have issued various quarantine measures (and in most cases complete lockdowns) to prevent COVID-19 from spreading further. Leading medical experts around the globe anticipate that incidents of COVID-19 will peak in the next two months, and thus will be critical for containing the virus. Each day, more cases of COVID-19 are becoming increasingly prevalent, and its impact is felt in all industries, including cannabis, America’s fastest-growing industry to date.
Adult-use cannabis sales kicked off in Michigan on December 1, 2019, nearly one year after voters approved the Michigan Regulation and Taxation of Marihuana Act (MRTMA), which passed in November of 2018. Despite minimal retailers to purchase from due to municipal opt-outs, adult-use cannabis transactions reached $6.5 million within the first month. The state’s House Fiscal Agency estimates that annual adult-use cannabis sales could approach $949 million when the market matures, and Marijuana Business Daily is estimating closer to $1.4 to $1.7 billion.
California is the country’s most populous and diverse state, with a population of 39.75 million. It also has the country’s largest legal and illicit cannabis markets, boasting a projected legal recreational sales value of $6.59 billion by 2025. Its illicit market, however, continues to thrive, posing a significant threat to the legal industry across multiple regulated municipalities. In 2019, California’s illicit cannabis market was projected to reach approximately $8.7 billion in sales, but its legal market wasn’t projected to reach even half of that ($3.1 billion). The two primary culprits of California’s thriving illicit market have been identified as sky-high sales tax (up to 25% depending on the municipality) and the fact that there aren’t enough retail stores to meet adult-use demand. Only 89 of California’s 482 cities allow cannabis retailers, making access to legal cannabis difficult or impossible for 393 cities across the state. Additionally, only about 800 of the 6,000 licenses anticipated are open for business due to “overly burdensome regulations,” resulting in the state revenue resting at about a third of what was expected.
Voters in Maine legalized adult-use cannabis on November 8, 2016, with the passage of the Marijuana Legalization Act, which would have regulated adult-use cannabis like alcohol. When it came time for state lawmakers to draft regulations for the program, however, significant setbacks began, chiefly due to the intervention of the state’s former Governor, Paul LePage. In November of 2017, almost exactly one year after voter approval, LePage vetoed a more conservative draft of the bill that would have regulated and taxed recreational cannabis in the state. Again, in 2018, he vetoed another version of the bill, more restrictive than the last. The legislature overturned LePage’s second veto, however, with the enactment of LD 1719, which became law on May 2, 2018. In January of 2019, LePage’s second term ended and pro-cannabis democratic governor, Janet Mills replaced him, ushering in a promising era for the state’s recreational legalization efforts. One month later, Mills created the Office of Marijuana Policy and, on June 27, 2019, signed newly proposed rules to govern Maine’s adult-use program (LD 719—An Act To Amend the Adult Use Marijuana Law). The new rules went into effect in September, with Maine’s Department of Administrative and Financial Services’ newly formed Office of Marijuana Policy finally publishing adult-use marijuana establishment applications in a staggered roll-out from Nov 4 to Dec 5, 2019.
Illinois Recreational Cannabis Market: New License Applications Available for Craft Growers, Infusers, and Transporters
The Illinois adult-use cannabis market opened for business on January 1, 2020. In the first five days alone, Illinois sold more than$10.8 millionworth of adult-use flower, edibles, vape cartridges, and other cannabis products. However, dwindling adult-use supply has caused widespread shortages forcing dispensaries to close their doors to recreational consumers.The only shops currently supplying the adult-use market are previously licensed medical dispensaries that are required by law to prioritize their patients. Adult-use supply became an issue only one week into legal sales, a problem that cannabis industry experts and operators predicted months ago, especially since the number of Illinois medical patients doubled over the last year.